Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.


PURPOSE Currently, treatment recommendations for small-cell urothelial cancer (SCUC) are based on anecdotal case reports and small retrospective series. We now report results from the first phase II clinical trial developed exclusively for SCUC, to our knowledge. PATIENTS AND METHODS From 2001 to 2006, 30 patients with SCUC provided consent and were… (More)
DOI: 10.1200/JCO.2008.19.0256


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.